Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

pembrolizumab 1266Specimen Handling 927Magnetic Resonance Spectroscopy 835Carboplatin 825Cyclophosphamide 804Cisplatin 726Nivolumab 666Paclitaxel 630Radiotherapy 609Gemcitabine 571Biopsy 561Bevacizumab 481Dexamethasone 439fludarabine 409Docetaxel 377venetoclax 368Oxaliplatin 364Fluorouracil 356Capecitabine 355atezolizumab 351durvalumab 334Rituximab 332Drug Therapy 325Doxorubicin 317Radiosurgery 315Blood Specimen Collection 310Standard of Care 310Pemetrexed 305Ipilimumab 297Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Secretome × 1 year × Clear all
NCT05279768 2026-02-25

Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.

PT. Prodia Stem Cell Indonesia

Phase 1/2 Completed
44 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡